Endo Buys Six Injectables Amid Shattering Decline In EBITDA Guidance

‘Our Focus Is On Driving Long-Term EBITDA Growth,’ Endo Insists

 
• By Dean Rudge
  
Expanding portfolio is Endo's first priority • Source: OleksandrShnuryk/Shutterstock

More from Deals

More from Business